Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

v3.22.2
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net loss $ (1,230,985) $ (370,431)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 11,357 7,146
Reduction in the carrying amount of right-of-use assets 14,117 12,012
Stock-based compensation 75,525 78,438
Goodwill impairment 1,000,081 0
Change in fair value of derivative liabilities (105,688) 0
Non-cash severance 0 7,873
Change in deferred tax asset valuation allowance 0 (2,638)
Other 966 2,106
Changes in operating assets and liabilities:    
Contract asset 32,538 0
Prepaid expenses and other current assets 16,835 1,847
Other assets (568) (2,872)
Accounts payable (9,517) (3,389)
Operating lease liabilities (12,384) (14,553)
Contract liability 91 50,000
Accrued expenses and other current and non-current liabilities (17,810) (48,491)
Net cash used in operating activities (225,442) (282,952)
Cash flows from investing activities    
Purchases of property and equipment (9,298) (13,128)
Net cash acquired in acquisitions 0 294,439
Purchase of short-term investments (966,063) 0
Maturities of short-term investments 133,000 0
Net cash (used in) provided by investing activities (842,361) 281,311
Cash flows from financing activities    
Proceeds from issuance of common stock 8,580 2,246
Proceeds from issuance of Series U-2 preferred stock, net 0 397,862
Other (1,233) 0
Net cash provided by financing activities 7,347 400,108
Net (decrease) increase in cash, cash equivalents and restricted cash (1,060,456) 398,467
Cash, cash equivalents, and restricted cash at beginning of the period 1,626,247 399,828
Cash, cash equivalents, and restricted cash at end of the period $ 565,791 $ 798,295